Bendic Health Care Private Limited

Glitozest-MV Tablets are a triple-combination oral anti-diabetic therapy formulated for comprehensive management of Type 2 Diabetes Mellitus. This advanced combination targets multiple pathways of glucose dysregulation insulin secretion, insulin resistance, and post-meal glucose absorption to deliver effective and sustained glycemic control.

How It Works:

• Glimepiride: Stimulates insulin release from pancreatic beta cells

• Metformin: Reduces hepatic glucose production and improves insulin sensitivity

• Voglibose: Delays intestinal carbohydrate absorption to control post-prandial spikes

Key Benefits & Uses:

• Improves fasting and post-prandial blood glucose levels

• Helps achieve better HbA1c reduction

• Controls post-meal hyperglycemia effectively

• Suitable for patients inadequately controlled on dual therapy

• Supports once- or twice-daily regimens as prescribed

Why Choose Glitozest-MV:

• Multi-mechanism action in a single tablet

• Simplifies complex diabetes regimens and improves adherence

• Manufactured under stringent quality standards by Bendic Healthcare Pvt. Ltd.

Ideal For:
Diabetologists, physicians, hospitals, and retail pharmacies seeking a dependable Glimepiride + Metformin + Voglibose tablet for advanced Type 2 diabetes management.